ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.177,62
-0,90%
S&P 500
5.469,30
0,39%
Dow Jones
39.112,16
-0,76%
Euro vs US Dollar
1,07142
0,05%
Bitcoin
62.072,87
0,44%
Registration Strip Icon for alerts Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. USOTC
  6. Retinalgenix Technologies Inc (QB) (RTGN)

  7. Retinalgenix Technologies Inc (QB) (RTGN) News

RTGN

Retinalgenix Technologies (QB) (RTGN)

Retinalgenix Technologies Inc (QB)
Von:
Sortieren nach:
 Showing the most relevant articles for your search:USOTC:RTGN
DatumZeitQuelleÜberschriftSymbolFirma
20/05/202415h46Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]USOTC:RTGNRetinalgenix Technologies Inc (QB)
16/05/202422h05Edgar (US Regulatory)Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSBUSOTC:RTGNRetinalgenix Technologies Inc (QB)
13/05/202406h15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessUSOTC:RTGNRetinalgenix Technologies Inc (QB)
13/05/202406h15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessUSOTC:RTGNRetinalgenix Technologies Inc (QB)
13/02/202406h15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessUSOTC:RTGNRetinalgenix Technologies Inc (QB)
13/02/202406h15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessUSOTC:RTGNRetinalgenix Technologies Inc (QB)
09/02/202423h10Edgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesUSOTC:RTGNRetinalgenix Technologies Inc (QB)
06/02/202423h30Edgar (US Regulatory)Form POS AM - Post-Effective amendments for registration statementUSOTC:RTGNRetinalgenix Technologies Inc (QB)
29/12/202322h49Edgar (US Regulatory)Form POS AM - Post-Effective amendments for registration statementUSOTC:RTGNRetinalgenix Technologies Inc (QB)
29/12/202322h40Edgar (US Regulatory)Form POS AM - Post-Effective amendments for registration statementUSOTC:RTGNRetinalgenix Technologies Inc (QB)
06/12/202322h05Edgar (US Regulatory)Form 8-K - Current reportUSOTC:RTGNRetinalgenix Technologies Inc (QB)
04/12/202315h46Edgar (US Regulatory)Form 8-K - Current reportUSOTC:RTGNRetinalgenix Technologies Inc (QB)
14/11/202312h21Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]USOTC:RTGNRetinalgenix Technologies Inc (QB)
06/11/202320h22Edgar (US Regulatory)Form POS AM - Post-Effective amendments for registration statementUSOTC:RTGNRetinalgenix Technologies Inc (QB)
06/11/202320h21Edgar (US Regulatory)Form POS AM - Post-Effective amendments for registration statementUSOTC:RTGNRetinalgenix Technologies Inc (QB)
14/08/202313h23Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]USOTC:RTGNRetinalgenix Technologies Inc (QB)
15/06/202316h49Edgar (US Regulatory)Amended Annual Report (10-k/a)USOTC:RTGNRetinalgenix Technologies Inc (QB)
18/05/202322h56Edgar (US Regulatory)Quarterly Report (10-q)USOTC:RTGNRetinalgenix Technologies Inc (QB)
16/05/202312h05Edgar (US Regulatory)Notification That Quarterly Report Will Be Submitted Late (nt 10-q)USOTC:RTGNRetinalgenix Technologies Inc (QB)
31/03/202322h01Edgar (US Regulatory)Annual Report (10-k)USOTC:RTGNRetinalgenix Technologies Inc (QB)
17/11/202221h31Edgar (US Regulatory)Quarterly Report (10-q)USOTC:RTGNRetinalgenix Technologies Inc (QB)
15/08/202223h35Edgar (US Regulatory)Notification That Quarterly Report Will Be Submitted Late (nt 10-q)USOTC:RTGNRetinalgenix Technologies Inc (QB)
28/07/202215h12Edgar (US Regulatory)Current Report Filing (8-k)USOTC:RTGNRetinalgenix Technologies Inc (QB)
07/07/202215h25Edgar (US Regulatory)Current Report Filing (8-k)USOTC:RTGNRetinalgenix Technologies Inc (QB)
22/06/202212h03Edgar (US Regulatory)Notice of Effectiveness (effect)USOTC:RTGNRetinalgenix Technologies Inc (QB)
21/06/202212h02Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)USOTC:RTGNRetinalgenix Technologies Inc (QB)
21/06/202212h02Edgar (US Regulatory)Withdrawal of Registration Statement (ammendment) (aw)USOTC:RTGNRetinalgenix Technologies Inc (QB)
13/06/202222h16Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)USOTC:RTGNRetinalgenix Technologies Inc (QB)
09/06/202212h06Edgar (US Regulatory)Notice of Effectiveness (effect)USOTC:RTGNRetinalgenix Technologies Inc (QB)
06/06/202222h49Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)USOTC:RTGNRetinalgenix Technologies Inc (QB)
 Showing the most relevant articles for your search:USOTC:RTGN

Kürzlich von Ihnen besucht

BIT
P1PSY1
BNP Paribas Issuance
EU
VTA
Volta Finance
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten